Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03543189
Title Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

prostate cancer

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.